Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma

NCT00596219 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

SQUAMOUS CELL CARCINOMA

Interventions

DRUG: celecoxib

Sponsor

Memorial Sloan Kettering Cancer Center